Stock data
DataMeds AI, Inc. (MEDS)
DataMeds AI, Inc. (MEDS) reported revenue of US$23.34M and net income of -US$101.27M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$23.34M | -US$6.43M | -US$93.75M | -US$101.27M | — |
| 2024 | US$18.13M | US$1.77M | -US$6.15M | -US$6.86M | — |
| 2023 | — | — | -US$2.88M | -US$2.90M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$1.78M | -US$18.36M | — |
| 2026-03-31 | US$1.56M | -US$7.74M | — |
| 2025-12-31 | US$1.67M | -US$27.85M | — |
| 2025-09-30 | US$3.01M | -US$34.32M | — |
| 2025-06-30 | US$7.79M | -US$6.67M | — |
| 2025-03-31 | US$10.86M | -US$32.43M | — |
| 2024-12-31 | — | -US$4.33M | — |
| 2024-09-30 | US$5.67M | -US$1.87M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.